“IN SILICO INVESTIGATION AND DOCKING STUDIES OF E2F3 TUMOR MARKER: DISCOVERY AND EVALUATION OF POTENTIAL INHIBITORS FOR PROSTATE AND BREAST CANCER”, Int. J. Pharm. Sci. Drug Res., vol. 2, no. 4, pp. 254–260, Oct. 2010, doi: 10.25004/IJPSDR.2010.020405.